Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
This is the only Eden static that labels both medications and both prices, so it avoids the $99-versus-$129 confusion that runs through the account. The hands holding two vials make the product the whole scene, and the warm, clean photo feels more premium than a chart. Forever is a strong word for a price, and putting it next to each number gives the viewer a promise to hold Eden to. Eden ran several versions of this creative from September 7, 2026.
There's no problem and nothing to make someone stop. The ad assumes the viewer is already comparing GLP-1 prices; anyone earlier in the decision sees two vials and two numbers and keeps scrolling. Add a short line above the prices that names what forever replaces (prices that rise as your dose goes up). Forever also deserves backing, so a small reference to the lifetime price guarantee from the landing page would make it a promise rather than a slogan.
Showing both products together sets up a clear choice between two options.
It labels each price with its medication and makes the price permanence the headline promise.
It repeats the flat price and adds the care promise.
Semaglutide at $99 a month and tirzepatide at $129 a month, both framed as forever, with pay as you go billing.
The ad lands on Eden's GLP-1 affiliate page, a focused landing page whose hero mirrors this creative closely: the same two medications with the same two prices side by side, a lifetime price guarantee in the ticker, and a Start my free assessment button. Someone who clicks sees exactly what the ad showed, plus the next step. The treatment comparison section further down is where a visitor would work out which of the two is for them.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.